OH-Blog Logo

Video: New Drug Offers New Hope for Multiple Sclerosis Patients

Meet Shawn Bollinger, an active Ohio teenager whose life was changed forever with an MS diagnosis. A new drug has helped change his life

Imagine being an active teenager, a baseball player, and have your life practically stop — with the diagnosis of multiple sclerosis (MS). For Shawn Bollinger, he didn’t have to imagine this, he’s lived it.

MS is an autoimmune condition where your own immune system attacks parts of your brain and spinal cord. Shawn was diagnosed with MS as a teenager. Now, as a young adult, he’s seen his life change — for the better — thanks to a new treatment, called alemtuzumab (brand name Lemtrada).

The FDA approved Lemtrada in late 2014 for the treatment of patients with relapsing forms of MS. The FDA recommends that Lemtrada be reserved for people who have had little relief with two or more MS therapies — patients like Shawn.

OhioHealth has followed Shawn’s journey over the past year, from his treatment of five infusions over 5 days, to his follow up appointments with Aaron Boster, MD, Bollinger’s OhioHealth neurologist and MS expert.

Learn more about innovative MS therapies and clinical trials happening at OhioHealth’s multidisciplinary MS clinic.